Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial

SIMPLE SUMMARY: Patients with medulloblastoma receive treatment according to a risk stratification, which is a combination of clinical and biological factors. To date there have been a limited number of trials for high-risk disease in children older than 3 years, with a wide range of treatment philo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bailey, Simon, André, Nicolas, Gandola, Lorenza, Massimino, Maura, Rutkowski, Stefan, Clifford, Steven C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773789/
https://www.ncbi.nlm.nih.gov/pubmed/35053536
http://dx.doi.org/10.3390/cancers14020374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773789/
https://www.ncbi.nlm.nih.gov/pubmed/35053536
http://dx.doi.org/10.3390/cancers14020374

Ejemplares similares